Price
No data yet.
Social Signal Score
Company Profile
- Sector
- Financial Services
- Industry
- Asset Management - Leveraged
- Beta
- 6.02
- Country
- US
Quote
Valuation & Ratios
Returns & Efficiency
Valuation
KORUhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
120+9.09%Social Signal Score
Mentions (5)
- Newsseekingalpha.com·9d ago·Positive
KORU Is On The Mend KORU Medical Systems is rated Buy at $3.50, as Q3 results signal recovery from temporary headwinds. KRMD's FY26 guidance was raised, with revenue expected at $48.0M–$48.5M (17–18% growth) and gross margin at 63–64%. Core SCIg business remains strong (+11.2% y/y), gross margin expanded 500bp, and pipeline initiatives support future growth.
View source ↗ - Newsseekingalpha.com·52d ago·Neutral
KORU: The Victim Of South Korea's Semiconductor Bottleneck The Direxion Daily MSCI South Korea Bull 3X ETF is a highly leveraged, volatile ETF now dominated by semiconductor exposure, especially Samsung and SK hynix. KORU's 'Strong Buy' quant rating should be ignored; it's well known that the quant system doesn't account for the ETF's structural risks, leverage decay, or extreme concentration. Despite past momentum, KORU's design ensures long-term underperformance versus its index and amplifies …
View source ↗ - Newsetftrends.com·87d ago·Positive
Is It Time to Cozy up to KORU Again? There's no shortage of stocks that provide risk-tolerant traders with excitement. Plenty of ETFs accomplish that objective, too.
View source ↗ - Newsseekingalpha.com·92d ago·Negative
KORU Medical Systems Selloff Offers An Opportunity KORU Medical Systems is transforming into a digitally enabled drug delivery platform, leveraging secular tailwinds in at-home subcutaneous infusion therapies. Q2 revenue grew 18.2% to $12.05M with positive net income and gross margin expansion to 65.1%, driven by domestic core strength and international growth. International ramp is slower than forecast, prompting narrowed FY guidance to $47.5M–$48.5M revenue and a raised gross margin outlook to…
View source ↗ - Newsseekingalpha.com·101d ago·Neutral
KORU: The Korean Paradox: Record Profits, Prices At Their Lows The Direxion Daily MSCI South Korea Bull 3X ETF (KORU) has fallen 73% from its highs while the KOSPI dropped 38%, even though SK Hynix's operating profit grew 500% in the same period. The KOSPI's forward P/E fell to 4.5x and its earning yield rose to 22%, driven mainly by forced margin call liquidations rather than weaker earnings. FLKR's daily RSI has already shown a V-shaped recovery near the 30 level, signaling renewed demand inte…
View source ↗
Congress trades
No disclosed congressional trades in KORU.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
